IVDの東南アジア市場

【英語タイトル】Southeast Asia IVD (In Vitro Diagnostics) Market Size, Status and Forecast 2020-2026

QYResearchが出版した調査資料(HNI090SP300)・商品コード:HNI090SP300
・発行会社(調査会社):QYResearch
・発行日:2020年11月
・ページ数:約100
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:東南アジア
・産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥405,600見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥608,400見積依頼/購入/質問フォーム
Enterprise License(法人閲覧用)USD7,800 ⇒換算¥811,200見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

In 2019, the Southeast Asia IVD (In Vitro Diagnostics) market size was US$ XX million and it is expected to reach US$ XX million by the end of 2026, with a CAGR of XX during 2020-2026.
IVD (In Vitro Diagnostics) market is segmented by players, region (country), by Type, and by Application. Players, stakeholders, and other participants in the Southeast Asia IVD (In Vitro Diagnostics) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Segment by Type
 Immuno Diagnostics
 Chemistry Diagnostics
 Molecular Diagnostics
 POCT
 Other

Segment by Application
 Hospitals
 Laboratory
 Other

By Region
 Philippines
 Vietnam
 Singapore
 Indonesia
 Thailand
 Malaysia

By Company
 Roche
 Abbott
 Danaher
 Siemens Healthineers
 Thermo Fisher Scientific
 Sysmex
 Biomerieux
 Ortho Clinical Diagnostics
 Becton Dickinson
 Bio-Rad Laboratories
 Hologic
 Johnson and Johnson
 …

【レポートの目次】

1 REPORT OVERVIEW
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Southeast Asia IVD (In Vitro Diagnostics) Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Immuno Diagnostics
1.2.3 Chemistry Diagnostics
1.2.4 Molecular Diagnostics
1.2.5 POCT
1.2.6 Other
1.3 Market by Application
1.3.1 Southeast Asia IVD (In Vitro Diagnostics) Market Share by Application: 2020 VS 2026
1.3.2 Hospitals
1.3.3 Laboratory
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 SOUTHEAST ASIA GROWTH TRENDS
2.1 Southeast Asia IVD (In Vitro Diagnostics) Market Perspective (2015-2026)
2.2 IVD (In Vitro Diagnostics) Growth Trends by Regions
2.2.1 IVD (In Vitro Diagnostics) Market Size by Regions: 2020 VS 2026
2.2.2 IVD (In Vitro Diagnostics) Historic Market Size by Regions (2015-2020)
2.2.3 IVD (In Vitro Diagnostics) Forecasted Market Size by Regions (2021-2026)
2.3 IVD (In Vitro Diagnostics) Industry Dynamic
2.3.1 IVD (In Vitro Diagnostics) Market Trends
2.3.2 IVD (In Vitro Diagnostics) Market Drivers
2.3.3 IVD (In Vitro Diagnostics) Market Challenges
2.3.4 IVD (In Vitro Diagnostics) Market Growth Strategy
2.3.5 Porter’s Five Forces Analysis
2.3.6 Primary Interviews with Key IVD (In Vitro Diagnostics) Players (Opinion Leaders)
3 MARKET ANALYSIS BY KEY PLAYERS
3.1 Southeast Asia Top IVD (In Vitro Diagnostics) Players by Market Size
3.1.1 Southeast Asia Top IVD (In Vitro Diagnostics) Players by Revenue (2015-2020)
3.1.2 Southeast Asia IVD (In Vitro Diagnostics) Revenue Market Share by Players (2015-2020)
3.1.3 Southeast Asia IVD (In Vitro Diagnostics) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Southeast Asia IVD (In Vitro Diagnostics) Market Concentration Ratio
3.2.1 Southeast Asia IVD (In Vitro Diagnostics) Market Concentration Ratio (CR5 and HHI)
3.2.2 Southeast Asia Top 10 and Top 5 Companies by IVD (In Vitro Diagnostics) Revenue in 2019
3.3 IVD (In Vitro Diagnostics) Key Players Head office and Area Served
3.4 Key Players IVD (In Vitro Diagnostics) Product Solution and Service
3.5 Date of Enter into IVD (In Vitro Diagnostics) Market
3.6 Mergers & Acquisitions, Expansion Plans
4 IVD (IN VITRO DIAGNOSTICS) BREAKDOWN DATA BY TYPE
4.1 Southeast Asia IVD (In Vitro Diagnostics) Historic Market Size by Type (2015-2020)
4.2 Southeast Asia IVD (In Vitro Diagnostics) Forecasted Market Size by Type (2021-2026)
5 IVD (IN VITRO DIAGNOSTICS) BREAKDOWN DATA BY APPLICATION
5.1 Southeast Asia IVD (In Vitro Diagnostics) Historic Market Size by Application (2015-2020)
5.2 Southeast Asia IVD (In Vitro Diagnostics) Forecasted Market Size by Application (2021-2026)
6 PHILIPPINES
6.1 Philippines IVD (In Vitro Diagnostics) Market Size (2015-2026)
6.2 IVD (In Vitro Diagnostics) Key Players in Philippines (2019-2020)
6.3 Philippines IVD (In Vitro Diagnostics) Market Size by Type (2015-2020)
6.4 Philippines IVD (In Vitro Diagnostics) Market Size by Application (2015-2020)
7 VIETNAM
7.1 Vietnam IVD (In Vitro Diagnostics) Market Size (2015-2026)
7.2 IVD (In Vitro Diagnostics) Key Players in Vietnam (2019-2020)
7.3 Vietnam IVD (In Vitro Diagnostics) Market Size by Type (2015-2020)
7.4 Vietnam IVD (In Vitro Diagnostics) Market Size by Application (2015-2020)
8 SINGAPORE
8.1 Singapore IVD (In Vitro Diagnostics) Market Size (2015-2026)
8.2 IVD (In Vitro Diagnostics) Key Players in Singapore (2019-2020)
8.3 Singapore IVD (In Vitro Diagnostics) Market Size by Type (2015-2020)
8.4 Singapore IVD (In Vitro Diagnostics) Market Size by Application (2015-2020)
9 INDONESIA
9.1 Indonesia IVD (In Vitro Diagnostics) Market Size (2015-2026)
9.2 IVD (In Vitro Diagnostics) Key Players in Indonesia (2019-2020)
9.3 Indonesia IVD (In Vitro Diagnostics) Market Size by Type (2015-2020)
9.4 Indonesia IVD (In Vitro Diagnostics) Market Size by Application (2015-2020)
10 THAILAND
10.1 Thailand IVD (In Vitro Diagnostics) Market Size (2015-2026)
10.2 IVD (In Vitro Diagnostics) Key Players in Thailand (2019-2020)
10.3 Thailand IVD (In Vitro Diagnostics) Market Size by Type (2015-2020)
10.4 Thailand IVD (In Vitro Diagnostics) Market Size by Application (2015-2020)
11 MALAYSIA
11.1 Malaysia IVD (In Vitro Diagnostics) Market Size (2015-2026)
11.2 IVD (In Vitro Diagnostics) Key Players in Malaysia (2019-2020)
11.3 Malaysia IVD (In Vitro Diagnostics) Market Size by Type (2015-2020)
11.4 Malaysia IVD (In Vitro Diagnostics) Market Size by Application (2015-2020)
12 KEY PLAYERS PROFILES
12.1 Roche
12.1.1 Roche Company Details
12.1.2 Roche Business Overview
12.1.3 Roche IVD (In Vitro Diagnostics) Introduction
12.1.4 Roche Revenue in IVD (In Vitro Diagnostics) Business (2015-2020)
12.1.5 Roche Recent Developments
12.2 Abbott
12.2.1 Abbott Company Details
12.2.2 Abbott Business Overview
12.2.3 Abbott IVD (In Vitro Diagnostics) Introduction
12.2.4 Abbott Revenue in IVD (In Vitro Diagnostics) Business (2015-2020)
12.2.5 Abbott Recent Developments
12.3 Danaher
12.3.1 Danaher Company Details
12.3.2 Danaher Business Overview
12.3.3 Danaher IVD (In Vitro Diagnostics) Introduction
12.3.4 Danaher Revenue in IVD (In Vitro Diagnostics) Business (2015-2020)
12.3.5 Danaher Recent Developments
12.4 Siemens Healthineers
12.4.1 Siemens Healthineers Company Details
12.4.2 Siemens Healthineers Business Overview
12.4.3 Siemens Healthineers IVD (In Vitro Diagnostics) Introduction
12.4.4 Siemens Healthineers Revenue in IVD (In Vitro Diagnostics) Business (2015-2020)
12.4.5 Siemens Healthineers Recent Developments
12.5 Thermo Fisher Scientific
12.5.1 Thermo Fisher Scientific Company Details
12.5.2 Thermo Fisher Scientific Business Overview
12.5.3 Thermo Fisher Scientific IVD (In Vitro Diagnostics) Introduction
12.5.4 Thermo Fisher Scientific Revenue in IVD (In Vitro Diagnostics) Business (2015-2020)
12.5.5 Thermo Fisher Scientific Recent Developments
12.6 Sysmex
12.6.1 Sysmex Company Details
12.6.2 Sysmex Business Overview
12.6.3 Sysmex IVD (In Vitro Diagnostics) Introduction
12.6.4 Sysmex Revenue in IVD (In Vitro Diagnostics) Business (2015-2020)
12.6.5 Sysmex Recent Developments
12.7 Biomerieux
12.7.1 Biomerieux Company Details
12.7.2 Biomerieux Business Overview
12.7.3 Biomerieux IVD (In Vitro Diagnostics) Introduction
12.7.4 Biomerieux Revenue in IVD (In Vitro Diagnostics) Business (2015-2020)
12.7.5 Biomerieux Recent Developments
12.8 Ortho Clinical Diagnostics
12.8.1 Ortho Clinical Diagnostics Company Details
12.8.2 Ortho Clinical Diagnostics Business Overview
12.8.3 Ortho Clinical Diagnostics IVD (In Vitro Diagnostics) Introduction
12.8.4 Ortho Clinical Diagnostics Revenue in IVD (In Vitro Diagnostics) Business (2015-2020)
12.8.5 Ortho Clinical Diagnostics Recent Developments
12.9 Becton Dickinson
12.9.1 Becton Dickinson Company Details
12.9.2 Becton Dickinson Business Overview
12.9.3 Becton Dickinson IVD (In Vitro Diagnostics) Introduction
12.9.4 Becton Dickinson Revenue in IVD (In Vitro Diagnostics) Business (2015-2020)
12.9.5 Becton Dickinson Recent Developments
12.10 Bio-Rad Laboratories
12.10.1 Bio-Rad Laboratories Company Details
12.10.2 Bio-Rad Laboratories Business Overview
12.10.3 Bio-Rad Laboratories IVD (In Vitro Diagnostics) Introduction
12.10.4 Bio-Rad Laboratories Revenue in IVD (In Vitro Diagnostics) Business (2015-2020)
12.10.5 Bio-Rad Laboratories Recent Developments
12.11 Hologic
12.11.1 Hologic Company Details
12.11.2 Hologic Business Overview
12.11.3 Hologic IVD (In Vitro Diagnostics) Introduction
12.11.4 Hologic Revenue in IVD (In Vitro Diagnostics) Business (2015-2020)
12.11.5 Hologic Recent Developments
12.12 Johnson and Johnson
12.12.1 Johnson and Johnson Company Details
12.12.2 Johnson and Johnson Business Overview
12.12.3 Johnson and Johnson IVD (In Vitro Diagnostics) Introduction
12.12.4 Johnson and Johnson Revenue in IVD (In Vitro Diagnostics) Business (2015-2020)
12.12.5 Johnson and Johnson Recent Developments
13 ANALYST’S VIEWPOINTS/CONCLUSIONS
14 APPENDIX
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Disclaimer
14.3 Author Details



★調査レポート[IVDの東南アジア市場] (コード:HNI090SP300)販売に関する免責事項を必ずご確認ください。
★調査レポート[IVDの東南アジア市場]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆